ANNAPOLIS, Md., Oct. 30 /PRNewswire/ -- PharmAthene, Inc., a leading
biodefense company specializing in the development and commercialization of
medical countermeasures against chemical and biological terrorism,
announced today that it is scheduled to present at the Rodman & Renshaw /
Acumen BioFin 9th Annual Healthcare Conference on Tuesday, November 6, 2007
at 10:55 a.m. local time. Presenting for the Company will be David P.
Wright, President and Chief Executive Officer. The conference is being held
at the New York Palace Hotel in New York City, NY.
A webcast of the Company's presentation will be available both live,
and via replay through a link provided on the Company's website at
http://www.pharmathene.com under the Investor Relations section, or at
http://www.wsw.com/webcast/rrshq12/pip.
About PharmAthene, Inc.
PharmAthene (AMEX: PIP) was formed to meet the critical needs of the
United States and its Allies by developing and commercializing medical
countermeasures against biological and chemical weapons. PharmAthene's lead
programs include Valortim(TM) for the prevention and treatment of anthrax
infection and Protexia(R) for the prevention and treatment of morbidity and
mortality associated with exposure to chemical nerve agents. For more
information on PharmAthene, please visit http://www.PharmAthene.com.
SOURCE PharmAthene, Inc.
 back to top
Related links:
http://www.pharmathene.com
http://www.wsw.com/webcast/rrshq12/pip
CONTACT:
Stacey Jurchison, Director, Corporate
Communications of PharmAthene, Inc., +1-410-269-2610,
+1-410-474-8200 (cell), JurchisonS@PharmAthene.com
|
